by Bektas, N. et al.
Institute of Pathology, University Hospital of the RWTH Aachen, Aachen, Germany
Institute of Pathology, University Hospital of the RWTH Aachen, Aachen, Germany
We found a positive correlation between FOXM1 expression and HER2 status, pointing to a potential role of FOXM1 as a new drug target in HER2 resistant breast tumour, as FOXM1 inhibitors for cancer treatment were described recently.
BMC. Cancer. 2008; 42
